|
|
|
 |
|
|
|
 Formulations
Overview
 After making a successful entry in API business in both Domestic & International markets, it was felt that new market segments are needed to be explored to increase the Brand Equity, growth, as well as profitability of the company.A very crucial decision was taken to focus towards the branded segments and this marked its entry into formulations business to cater to the mass directly as a part of vertical expansion strategy.
Our formulation business is focused on multiple streams of opportunity
| • |
Indian operations branded as “Safe Med” |
| • |
Export operations with focus only in the Rest of the World markets (all countries other than EU , USA) |
| • |
P2P/Contract Manufacturing with our new range of molecules for Major Indian and ROW generic players |
SAFE and Strong Medicines
Our strategy is constantly explore innovative solutions to offer safe and quality products at competitive prices. With Synergistic backward integration with our APIs we extend an aggressive pipe line of products on a very aggressive time lines.
We have successfully been building our brand based on the values of service and quality.
We offer major products ranging from cardio-vascular, diabetic, anti-infectives, and supplementary vitamins and minerals, we develop two manufacturing various finished dosages and line extensions such as
Overall Solid Dosages
Tablets
Sugar coated
Film coated – including delayed release
Uncoated, Chewable
Capsules
Hard Gelatin
Small Volume Parenterals
| • |
Liquid Vials |
| • |
Liquid Ampoules |
| • |
Lyophilised Vials |
|
|
|
